nf-kappa b functions tumour promoter inflammation-associated cancer 
causes sporadic human cancer seldom recognized estimated carcinogen exposure chronic inflammation two important underlying conditions tumour development latter accounting approximately % human cancer whereas causal relationship carcinogen exposure cancer intensely investigated molecular cellular mechanisms linking chronic inflammation tumorigenesis remain largely unresolved proposed activation nuclear factor kappab nf-kappab hallmark inflammatory responses frequently detected tumours may constitute missing link inflammation cancer test hypothesis studied mdr2-knockout mouse strain spontaneously develops cholestatic hepatitis followed hepatocellular carcinoma prototype inflammation-associated cancer monitored hepatitis cancer progression mdr2-knockout mice show inflammatory process triggers hepatocyte nf-kappab upregulation tumour-necrosis factor-alpha tnfalpha adjacent endothelial inflammatory cells switching nf-kappab mice birth seven months age using hepatocyte-specific inducible ikappab-super-repressor transgene effect course hepatitis affect early phases hepatocyte transformation contrast suppressing nf-kappab inhibition anti-tnfalpha treatment induction ikappab-superrepressor later stages tumour development resulted apoptosis transformed hepatocytes failure progress hepatocellular carcinoma studies thus indicate nf-kappab essential promoting inflammation-associated cancer therefore potential target cancer prevention chronic inflammatory diseases 
